A carregar...
Lamellar macular hole after intravitreal ocriplasmin injection
Intravitreal ocriplasmin was recently approved by the Food and Drug Administration to achieve medical vitreolysis in the setting of vitreomacular adhesion (VMA). We report a case of a 76-year-old woman who developed a lamellar macular hole following treatment with intravitreal ocriplasmin injection...
Na minha lista:
| Publicado no: | BMJ Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4289753/ https://ncbi.nlm.nih.gov/pubmed/25576512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2014-207810 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|